IFNA1 and chronic hepatitis B virus infection: Clinical trials have already used a combination of IFN and siRNA to treat chronic hepatitis B (37), but due to the difficulties in studying cccDNA, research on the effects of the combination has been mostly limited to antigen and RNA level.